Skip to main content
Equibles
EHC logo

EHC · Encompass Health Corp · Metrics

Track EHC — free

Use EHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$121.03 -0.49 (-0.40%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.88B
Shares
98.65M

EHC metrics

84 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$121.52
Market cap
$11.88B

Price action

20 metrics
Price change (1W)
-1.3%
Price change (30D)
-4.2%
Price change (3M)
+15.6%
Price change (6M)
+12.7%
Price change (YTD)
+13.5%
Price change (1Y)
-4.4%
Trailing year
Price change (5Y)
—
52-week high
$127.18
52-week low
$93.83
Change from 52-week high
-5.3%
Change from 52-week low
+28.4%
Annualized volatility
28.8%
Annualized volatility (3M)
33.3%
Beta
0.1
RSI (14D)
53.1
Price vs SMA 50
+4.2%
Price vs SMA 200
+12.3%
Avg volume (3M)
1.00M
Relative volume
0.8
Average dollar volume
$111.83M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
98.65M

Valuation

12 metrics
P / E (TTM)
19.6
Trailing earnings · reciprocal yield 5.1%
PEG ratio
1.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 52.2%
P / book
4.6
reciprocal yield 21.9%
FCF yield
3.5%
TTM · current market cap
Buyback yield
2.1%
P / FCF
28.7
reciprocal yield 3.5%
P / operating cash flow
9.8
reciprocal yield 10.2%
Earnings yield
5.2%

Historical valuation

8 metrics
P / E historical average (3Y)
21.3×
reciprocal yield 4.7%
P / E historical average (5Y)
20.9×
reciprocal yield 4.8%
EV / revenue historical average (3Y)
2.3×
reciprocal yield 44.0%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 47.2%
EV / EBIT historical average (3Y)
17.9×
reciprocal yield 5.6%
EV / EBIT historical average (5Y)
17.5×
reciprocal yield 5.7%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
12.1%
Shareholder yield
2.7%
Dividend / share (TTM)
$0.76
Dividend growth YoY
+11.8%
Dividend growth streak
1
Last ex-dividend
2026-07-01

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
10.0%
Gross profit (TTM)
—
Operating profit (TTM)
$539.50M
Net income (TTM)
$621.00M
Trailing 12 months
Diluted EPS (TTM)
$6.14
FCF margin
6.7%
Effective tax rate
20.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.6%
Year over year
Net income growth YoY
+8.3%
Revenue (TTM)
$6.21B
Trailing 12 months
EPS growth YoY
+10.8%
Shares change YoY
-2.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.9%
Revenue CAGR (5Y)
+10.7%
EPS CAGR (3Y)
+27.1%
EPS CAGR (5Y)
+14.2%
FCF CAGR (3Y)
+46.0%
FCF CAGR (5Y)
+7.1%

Quality

14 metrics
Return on equity
23.9%
Return on assets
8.3%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
$783.10M
Free cash flow (TTM)
$413.40M
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$107.70M
Total assets
$7.46B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.21B
Capital expenditures (TTM)
$799.10M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$58.00M
R&D / revenue
—
Stock compensation / revenue
0.9%

Ownership (13F)

3 metrics
13F filers
599
13F filer change QoQ
+15
Institutional ownership
96.3%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$26.43M
Insider-sentiment score
9 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 785161 CUSIP 29261A100 13F (30d) 296 filings 293 filers Visit website Investor relations